These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
791 related articles for article (PubMed ID: 34692770)
1. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Zheng H; Liu H; Li H; Dou W; Wang X Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770 [No Abstract] [Full Text] [Related]
2. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis. Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY Front Oncol; 2023; 13():1191660. PubMed ID: 37207166 [TBL] [Abstract][Full Text] [Related]
3. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer. Zheng H; Liu H; Ge Y; Wang X Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584 [TBL] [Abstract][Full Text] [Related]
4. Influential upregulation of KCNE4: Propelling cancer associated fibroblasts-driven colorectal cancer progression. Zhang Z; Liu S; Wang Z; Wang S; Jiang L; Wang X; Li J; Shen L Cancer Cell Int; 2024 Mar; 24(1):103. PubMed ID: 38462626 [TBL] [Abstract][Full Text] [Related]
5. A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response. Lv Y; Hu J; Zheng W; Shan L; Bai B; Zhu H; Dai S Transl Cancer Res; 2023 Sep; 12(9):2256-2275. PubMed ID: 37859738 [TBL] [Abstract][Full Text] [Related]
6. SNAI2 as a Prognostic Biomarker Based on Cancer-Associated Fibroblasts in Patients With Lung Adenocarcinoma. Li TT; Hao QG; Teng ZW; Liu Y; Wu JF; Zhang J; Yang LR Clin Med Insights Oncol; 2024; 18():11795549241280506. PubMed ID: 39314798 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer. Wu ZZ; Wei YJ; Li T; Zheng J; Liu YF; Han M World J Clin Cases; 2024 Feb; 12(4):700-720. PubMed ID: 38322675 [TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics. Gu L; Ding D; Wei C; Zhou D Front Oncol; 2023; 13():1158863. PubMed ID: 37404754 [TBL] [Abstract][Full Text] [Related]
9. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616 [TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer. Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH Front Genet; 2022; 13():1054152. PubMed ID: 36506313 [No Abstract] [Full Text] [Related]
11. Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma. Gu Y; Zhuo H Aging Male; 2023 Dec; 26(1):2233609. PubMed ID: 37428096 [TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature. Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384 [TBL] [Abstract][Full Text] [Related]
13. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer. Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C Front Immunol; 2022; 13():951214. PubMed ID: 35967313 [TBL] [Abstract][Full Text] [Related]
14. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
15. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma. Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of cancer-associated fibroblast signature in gastric cancer. Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related]
19. Development of a Cancer-associated Fibroblast Signature for Evaluating Immunotherapy Response and Prognosis of Hepatocellular Carcinoma. Xia H; Feng P; Wang W; Gong Z; Ran J; Lu P; Dai B Curr Med Chem; 2024 Jul; ():. PubMed ID: 39021175 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing. Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]